The relationship between sleep onset time and cardiometabolic biomarkers in Chinese communities: a cross-sectional study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
20 Mar 2020
Historique:
received: 18 12 2018
accepted: 12 03 2020
entrez: 22 3 2020
pubmed: 22 3 2020
medline: 8 8 2020
Statut: epublish

Résumé

Late sleep onset time (SOT) is a common social phenomenon in modern society, and it was associated with a higher risk of obesity. However, the literature gap exists about the SOT and cardiometabolic biomarkers which closely associated with obesity. The present study aimed to explore the association of SOT with cardiometabolic biomarkers in Chinese communities. A cross-sectional study enrolled a total of 2418 participants was conducted in Ningxia province of China. The cardiometabolic biomarkers included triglyceride, total cholesterol, high-density lipoprotein, low-density lipoprotein and fasting plasma glucose were measured quantitatively using the standard method. The SOT and sleep duration were acquired by a self-report questionnaire. The multiple mixed-effect linear regression model was employed to examine the association. Binary analysis found an inverse association of SOT with high-density lipoprotein (β = - 0.05, 95%CI: - 0.06, - 0.03), with 1 h delayed in SOT the high-density lipoprotein decreased 0.05 mmol/L. After controlling for demographic variables, health-related behaviors, and physical health covariates, late SOT was associated with a higher level of triglyceride (β = 0.12, 95%CI: 0.06, 0.18), a higher level of low-density lipoprotein (β = 0.06, 95% CI: 0.02, 0.09), and a lower level of high-density lipoprotein (β = - 0.05, 95% CI: - 0.06, - 0.03). when stratified by sleep duration (less than eight hours vs. eight and longer hours), a positive association between SOT and LDL (β = 0.08, 95% CI: 0.04, 0.12) was found among participants with sleep duration eight hours and longer. Late sleep onset time with the negative effect on the cardiometabolic biomarkers, and individuals with late SOT coupled with longer sleep duration may take risk of a higher level of low-density lipoprotein which in turn lead to increase the risk of cardiovascular disease.

Sections du résumé

BACKGROUND BACKGROUND
Late sleep onset time (SOT) is a common social phenomenon in modern society, and it was associated with a higher risk of obesity. However, the literature gap exists about the SOT and cardiometabolic biomarkers which closely associated with obesity. The present study aimed to explore the association of SOT with cardiometabolic biomarkers in Chinese communities.
METHODS METHODS
A cross-sectional study enrolled a total of 2418 participants was conducted in Ningxia province of China. The cardiometabolic biomarkers included triglyceride, total cholesterol, high-density lipoprotein, low-density lipoprotein and fasting plasma glucose were measured quantitatively using the standard method. The SOT and sleep duration were acquired by a self-report questionnaire. The multiple mixed-effect linear regression model was employed to examine the association.
RESULTS RESULTS
Binary analysis found an inverse association of SOT with high-density lipoprotein (β = - 0.05, 95%CI: - 0.06, - 0.03), with 1 h delayed in SOT the high-density lipoprotein decreased 0.05 mmol/L. After controlling for demographic variables, health-related behaviors, and physical health covariates, late SOT was associated with a higher level of triglyceride (β = 0.12, 95%CI: 0.06, 0.18), a higher level of low-density lipoprotein (β = 0.06, 95% CI: 0.02, 0.09), and a lower level of high-density lipoprotein (β = - 0.05, 95% CI: - 0.06, - 0.03). when stratified by sleep duration (less than eight hours vs. eight and longer hours), a positive association between SOT and LDL (β = 0.08, 95% CI: 0.04, 0.12) was found among participants with sleep duration eight hours and longer.
CONCLUSION CONCLUSIONS
Late sleep onset time with the negative effect on the cardiometabolic biomarkers, and individuals with late SOT coupled with longer sleep duration may take risk of a higher level of low-density lipoprotein which in turn lead to increase the risk of cardiovascular disease.

Identifiants

pubmed: 32197597
doi: 10.1186/s12889-020-08516-9
pii: 10.1186/s12889-020-08516-9
pmc: PMC7085179
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

374

Subventions

Organisme : the Research and Development Plan of the 13th five-year plan of Ningxia autonomous region
ID : 2016BZ02

Références

Sleep Med Rev. 2005 Apr;9(2):115-29
pubmed: 15737790
Ann N Y Acad Sci. 2008;1129:287-304
pubmed: 18591489
J Clin Endocrinol Metab. 2004 Nov;89(11):5762-71
pubmed: 15531540
Obesity (Silver Spring). 2010 Jul;18(7):1437-42
pubmed: 19851301
J Clin Diagn Res. 2014 Sep;8(9):BC05-7
pubmed: 25386421
Sleep Med. 2014 Dec;15(12):1586-9
pubmed: 25311835
J Clin Sleep Med. 2005 Oct 15;1(4):357-63
pubmed: 17564401
Sleep. 2010 May;33(5):585-92
pubmed: 20469800
Pediatr Endocrinol Rev. 2010 Mar-Apr;7(3):292-9
pubmed: 20526243
Arch Dis Child. 2006 Nov;91(11):881-4
pubmed: 17056861
J Clin Sleep Med. 2017 Jan 15;13(1):33-38
pubmed: 27707437
Obesity (Silver Spring). 2008 Mar;16(3):643-53
pubmed: 18239586
Nat Rev Endocrinol. 2016 Jan;12(1):1
pubmed: 26635110
Sleep. 2016 Feb 01;39(2):457-65
pubmed: 27091639
Sleep Med Rev. 2010 Jun;14(3):167-77
pubmed: 20093053
Int J Environ Res Public Health. 2015 Dec 23;13(1):ijerph13010019
pubmed: 26703640
Sleep. 2008 May;31(5):645-52
pubmed: 18517035
CMAJ. 2012 Nov 20;184(17):E913-20
pubmed: 23027917
Int J Obes Relat Metab Disord. 2000 Dec;24(12):1683-8
pubmed: 11126224
Int J Obes (Lond). 2013 Apr;37(4):546-51
pubmed: 23295498
Recent Pat Endocr Metab Immune Drug Discov. 2013 Jan;7(1):11-25
pubmed: 22946959
Pediatr Obes. 2014 Feb;9(1):17-25
pubmed: 23296488
Arch Intern Med. 2006 Sep 18;166(16):1689-92
pubmed: 16983045
Sleep. 2017 Apr 1;40(4):
pubmed: 28329091
Eur Heart J. 2011 Jun;32(12):1484-92
pubmed: 21300732
Nihon Eiseigaku Zasshi. 1989 Aug;44(3):725-32
pubmed: 2810873
Chronobiol Int. 2015;32(10):1469-76
pubmed: 26595483
Obesity (Silver Spring). 2017 Dec;25(12):2045-2048
pubmed: 28985039

Auteurs

Liqun Wang (L)

School of Public Health and Management, Ningxia Medical University, Yinchuan, 750004, China.

Jiangping Li (J)

School of Public Health and Management, Ningxia Medical University, Yinchuan, 750004, China.

Yong Du (Y)

Surgical Laboratory of General Hospital, Ningxia Medical University, Yinchuan, 750004, China.
School of Clinical Medicine, Ningxia Medical University, Yinchuan, 750004, China.

Ting Sun (T)

Surgical Laboratory of General Hospital, Ningxia Medical University, Yinchuan, 750004, China.

Li Na (L)

Surgical Laboratory of General Hospital, Ningxia Medical University, Yinchuan, 750004, China.

Zhizhong Wang (Z)

School of Public Health and Management, Ningxia Medical University, Yinchuan, 750004, China. wzhzh_lion@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH